Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Human Milk Oligosaccharides (HMO) Market Outlook to 2025: Anticipated to Record a CAGR of 21.9%, Driven by Growing Consumer Awareness Regarding Infant Health -

March 15, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Mar 15, 2019--The “Human Milk Oligosaccharides (HMO) Market Size, Share & Trends Analysis Report By Application (Food Supplements, Functional Food & Beverages, Infant Formula), By Region, And Segment Forecasts, 2018 - 2025” report has been added to’s offering.

The global human milk oligosaccharides (HMO) market size is expected to reach USD 71.2 billion by 2025. The HMO market is projected to witness a strong CAGR of 21.9% during the forecast period.


Growing consumer awareness regarding infant health is expected to be the key factor driving the market. Moreover, heavy investments by prominent companies in emerging economies is anticipated to fuel the industry growth. The global infant formula market was valued at over USD 45 billion in 2016, with Asia being the dominant region.

Increasing number of middle-class households and number of working women are among the key reasons behind the growth of the infant formula market. Presence of numerous companies and resultant competition in this sector is likely to facilitate the usage of HMO in infant formula over the forecast period, boosting the market growth.

High demand for dietary supplements owing to increased health consciousness is also expected to augment the market growth over the forecast period. HMOs in dietary supplements provide benefits, such as enhanced immune system and digestive comfort. For example, DuPont Nutrition & Health’s CARE4U is used as a dietary supplement ingredient.

The market witnessing intense competition due to the increasing number of market entrants. For instance, in June 2018, BASF announced that it will launch its HMO ingredient 2′FL by early 2019. Similarly, in June 2018, Abbott introduced its new infant formula product, Similac Eye-Q Plus with HMO, in Vietnam.

Further key findings from the study suggest:

  • In terms of revenue, the infant formula segment is expected to witness the fastest CAGR of 22% over the forecast period
  • North America accounted for a share of over 80% in 2017, in terms of revenue on account of early adoption of the product and presence of numerous infant formula companies in the region
  • Business expansion and product launch are the major strategies undertaken by major companies in the global HMO market
  • For instance, in November 2016, Inbiose NV partnered with DuPont Nutrition & Health and launched a new infant nutrition ingredient, based on complex carbohydrates found in human milk

Topics Covered

Chapter 1 Research Methodology

1.1 Research Methodology

1.2 Research Scope & Assumptions

1.3 List of Data Sources

Chapter 2 Executive Summary

Chapter 3 HMO Industry Outlook

3.1 HMO market segmentation

3.2 HMO market size and growth prospects, 2014-2025

3.3 HMO - Value chain analysis

3.3.1 Vendor landscape

3.4 Raw material outlook

3.5 Technology overview

3.6 Regulatory framework


3.6.1 European Commission: Regulation (EC) No 258/97 of the European Parliament

3.7 HMO market dynamics

3.7.1 Market driver analysis Positive dairy industry outlook Growing dietary supplements market Rising concerns towards gut health

3.7.2 Market restraints analysis High production and R&D cost

3.8 Key opportunities prioritized

3.9 HMO competitive landscape

3.9.1 Strategy Framework

3.10 HMO market: Porter’s analysis

3.11 HMO market PESTEL analysis

Chapter 4 HMO Product Outlook

4.1 2′-Fucosyllactose (2′FL)

4.2 3′-Fucosyllactose (3′FL)

4.3 3′-Sialyllactose (3′SL)

4.4 6′-Sialyllactose (6′SL)

4.5 Lacto-N-tetraose (LNT)

4.6 Lacto-N-neotetraose (LNnT)

Chapter 5 HMO Application Outlook

5.1 Global HMO market volume share, by application, 2017 & 2025

5.2 Infant Formula

5.3 Functional Food & Beverages

5.4 Food Supplements

5.5 Others

Chapter 6 HMO Regional Outlook

6.1 Global HMO market volume share by region, 2017 & 2025

6.2 North America

6.3 Europe

6.4 Asia Pacific

6.5 Latin America

6.6 MEA

Chapter 7 Competitive Landscape

7.1 Inbiose N.V.

7.2 Elicityl S.A.

7.3 Jennewein Biotechnologie GmbH

7.4 Glycom A/S

7.5 Medolac Laboratories

7.6 ZuChem Inc.

7.7 Glycosyn LLC

For more information about this report visit

View source version on


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Food Additives



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/15/2019 09:00 AM/DISC: 03/15/2019 09:01 AM